Prolonged Clinical Follow-up of OPTIMA-5

NCT05649696 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

DRUG: Recombinant Staphylokinase
DRUG: Normal Saline

Sponsor

The First Affiliated Hospital with Nanjing Medical University